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Table A1
Volume and Issue numbers for Health Technology Assessment monographs included in analysis of projects including trials with economic evaluations. Underlined issue numbers indicate those that contained at least on comparison that had "doubly null" results. (For example 8.46 in Volume 8 had a "doubly null" result.)
Year
Volume Issue 2004 Table A1 provides excerpts on the overall conclusions drawn in the abstracts of HTA published randomised trials with "doubly null" results, in which economics favours the intervention. The projects are divided into three groups, those with overall conclusions in favour of the intervention, the control and those which favoured neither, that is those which were uncertain 10 projects with "doubly null" results drew concluded in favour of the intervention. These were 21. 24, 20.93, 20.53, 19.88, 18.57, 18.36, 18.19 (3 comparisons) , 14.15 (2 comparisons) and 9.41 (2 comparisons). These contained 14 comparisons. (First section Table A2 .)
The 7 projects that included a conclusion in favour on the control were 20. 95, 20.60, 20.52, 20.41, 17.25, 17.07, 9.34 . These contained 7 comparisons. (Second section, Table A" .)
The 7 projects that concluded in favour of uncertainty were 21.12 (2 comparisons), 19.80, 19.38, 16.47,13.33, 10.22, 9.16 (2 comparisons) . These contained 9 comparisons. (Third section, Table A2 .)
The average probability of being cost effective at a willingness to pay of £20k per QALY is also shown for those comparisons for which this was available. For those overall comparisons in favour of an intervention the average probability of being cost effective was put at 82%. For those with conclusions favouring the control arm, the average was 79%. And for with mixed or uncertain conclusions the mean probability was 68%. The presence of other factors which might have influenced the overall conclusion is also noted where relevant. Table A1 HTA RCTs with "doubly null" results, in which economics favours the intervention, divided between those whose overall conclusions favour the intervention, control or were uncertain The supplementation of a home-based exercise programme with a class-based exercise programme led to superior improvement in the supplemented group. These differential improvements were still evident at review 12 months after treatment had ceased. The additional cost of the supplemented group was offset by reductions in resource use elsewhere in the system. Compliance with the home exercise programme did not differ between the groups. Based on this evidence, the supplementation of a home-based exercise programme with an 8-week class-based exercise programme can be confidently expected to produce small improvements in locomotor function and clinically important reductions in pain. There was no evidence of a benefit to child outcome of supplementing CCBT with either intervention focusing on maternal anxiety disorder or maternal cognitions and behaviours. However, supplementing CCBT with treatment that targeted maternal cognitions and behaviours represented a costeffective use of resources, although the high percentage of missing data on some economic variables is a shortcoming 75% MCI was seen as cost effective, MCBT was not.
70%

16.47
Nitrofurazoneimpregnated impregnated catheter versus standard Urinary tract infection "The trial estimate of clinical effectiveness for nitrofurazone-impregnated catheters was less than the pre-specified minimum absolute risk difference that we considered important (−3.3%), and the surrounding CI included zero, indicating that any reduction in catheter-associated UTI was uncertain. Economic analysis, although associated with uncertainty, suggested that nitrofurazoneimpregnated catheters may be cost-effective for the NHS."
80%
Cost effectiveness was based on modelling due to poor trial data.
13.33
Continuous positive airway pressure (CPAP) versus usual care pulmonary oedema "Non-invasive ventilatory support delivered by ….CPAP … safely provides earlier improvement and resolution of breathlessness, respiratory distress and metabolic abnormality. However, this does not translate into improved short-or longer-term survival."
71%
Primary outcome was 7 day mortality. Cost effectiveness based on long term modelling.
Pressure mattress versus underlay
Pressure sores "There is no difference between alternating pressure mattress replacements and overlays in terms of the proportion of patients developing new pressure ulcers; however, alternating pressure mattress replacements are more likely to be costsaving."
64% (dominance)
Difference in cost was due to duration not incidence of pressure sores.
